20th International Congress » Parkinson's disease: Non-motor symptoms

Date: Monday, June 20, 2016

Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Session Type: Poster Session

Meeting: 20th International Congress

12:30pm-2:00pm: A case of PD with non -motor symptoms onset

L. Khachatryan, N. Gasparyan, E. Mamyan, N. Mamyan, A. Hakobyan (Yerevan, Armenia)

12:30pm-2:00pm: A case series of sigmoid volvulus in Parkinson’s disease

K. Khalid, A. McColl, M. Gosney, A.K. Chatterjee (Reading, United Kingdom)

12:30pm-2:00pm: A computerized cognitive behavioral therapy randomized, controlled, pilot trial for insomnia in Parkinson’s disease (The ACCORD-PD study)

S. Patel, O. Ojo, G. Genc, L. Wang, J. Benab, M. Drerup, N. Foldvary, A. Ahmed, H.H. Fernandez (Cleveland, OH, USA)

12:30pm-2:00pm: Allele specificity in neurodegenerative olfactory dysfunction

B.A. Chase, K. Markopoulou, P. Robowski, A. Strongosky, E. Narozanska, E.J. Sitek, M. Berdynski, M. Barcikowska, M.C. Baker, R. Radamakers, J. Slawek, Z.K. Wszolek (Omaha, NE, USA)

12:30pm-2:00pm: Alpha-synuclein aggregates of cardiac sympathetic nerves in synucleinopathies and in neurologically unimpaired subjects. Correlation with sympathetic denervation

M. Carmona-Abellán, I. Marcilla, I. Martínez-Valbuena, T. Tuñón, R. Luquin-Piudo (Pamplona, Spain)

12:30pm-2:00pm: Analysis of the olfactory impairments in PINK1 deficient mice

A. Hummel, A. Zimprich, L. Garret, B. Sperling, F. Giesert, J. Nagler, H. Fuchs, V. Gailus-Durner, M. Hrabé de Angelis, S.M. Koch, D. Vogt Weisenhorn, W. Wurst (Neuherberg, Germany)

12:30pm-2:00pm: Anosmia predicts development of more severe motor symptoms including freezing of gait and impaired balance at 2 year follow-up in PD

N.I. Bohnen, J. Haugen, V. Kotagal, K.A. Frey, R.L. Albin, M.L.T.M. Muller (Ann Arbor, MI, USA)

12:30pm-2:00pm: Anxiety and freezing of gait: A new perspective for early intervention

K.A. Ehgoetz Martens, J.M. Hall, M. Gilat, M.J. Georgiades, C.C. Walton, S.J.G. Lewis (Camperdown, Australia)

12:30pm-2:00pm: Anxiety in patients with Parkinson’s disease

K. Zhu, J.J. van Hilten, J. Marinus (Leiden, Netherlands)

12:30pm-2:00pm: Anxiolytic-like activity of the adenosine A_2A receptor antagonist, istradefylline (KW-6002) in rodent models of anxiety

K. Yamada, M. Kobayashi, J. Kase, A. Mori, P. Jenner, T. Kanda (Shizuoka, Japan)

12:30pm-2:00pm: Apathy and striatal dopamine defects in non-demented patients with Parkinson’s disease

S.J. Chung, J.J. Lee, J.H. Ham, P.H. Lee, Y.H. Sohn (Seoul, Korea)

12:30pm-2:00pm: Application of Parkinson’s well-being map to assess impairment of digestive system in patients of Tomsk region, Russia

Y. Mironova, I. Zhukova, N. Zhukova, V. Alifirova, O. Izhboldina, A. Latypova, M. Nikitina (Tomsk, Russia)

12:30pm-2:00pm: Assessment of gait dysfunction in patients with Parkinson’s disease and REM behavioral disorder

L.R. Niemand, A. Dang, C. Singer, C.C. Luca (Miami, FL, USA)

12:30pm-2:00pm: Assessment of olfactory dysfunction in Parkinson’s disease with an objective test

Y. Sucullu Karadag, N. Turkmen, O. Gulten, A. Eryilmaz, A. Altundag, N. Subutay Oztekin, F. Ak (Ankara, Turkey)

12:30pm-2:00pm: Associated and predictive factors of depressive symptoms in patients with Parkinson’s disease

K. Zhu, J.J. Van Hilten, J. Marinus (Leiden, Netherlands)

12:30pm-2:00pm: Association of mood and affective disorders with pain in Parkinson’s disease

J.S. Kim, W. Jang, J. Park, E. Oh, J. Youn, J.W. Cho (Seoul, Korea)

12:30pm-2:00pm: Autonomic failure and circadian rhythm of arterial blood pressure in IDIOPATHIC REM behaviour disorders and Parkinson’s disease

R. Zangaglia, E. Guaschino, N. Ghiotto, B. Minafra, M. Terzaghi, G. Capone, A. Spiritelli, D. Bosone, C. Pacchetti (Pavia, Italy)

12:30pm-2:00pm: Awareness and perception of gastrointestinal symptoms in Parkinson´s disease: A survey of patients and caregiving relatives

P. Themann (Halsbrücke, Germany)

12:30pm-2:00pm: Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson’s disease. PPMI cohort

T. Simuni, D. Weintraub, C. Caspell-Garcia, M. Walker, C.S. Coffey, S. Lasch, C. Tanner, D. Jennings, K. Kieburtz, K. Marek, On behalf of the PPMI Investigators (Chicago, IL, USA)

12:30pm-2:00pm: Blunted perception of respiratory resistive loads in Parkinson’s disease

K.W. Hegland, M.S. Troche, M.S. Okun, A.E. Brandimore (Gainesville, FL, USA)

12:30pm-2:00pm: Body weight determinants in Parkinson’s disease: A multifactorial study

A. Bril, M. Rossi, S. Fariña, P. Morisset, L. Sorrentino, M. Iglesias, A. Medina Escobar, P. Millar Vernetti, D. Cerquetti, S. Perez Lloret, M. Merello (Buenos Aires, Argentina)

12:30pm-2:00pm: Bradykinesia of external urethral sphincter in a Patient with Parkinson’s disease: Case report

I.E. Estrada-Bellmann, A. Gutierrez, H.J. Villarreal, J.J. Peña, D. Ortiz (Monterrey, Mexico)

12:30pm-2:00pm: Cerebral vasoreactivity in Parkinson’s disease and multiple system atrophy: A pilot study

E. Indelicato, F.E. Pontieri, D. Benincasa, A. Fanciulli, F. Orzi, M. Giovannelli, G. Sette (Rome, Italy)

12:30pm-2:00pm: Characterization of burning mouth syndrome in patients with Parkinson’s disease

P.J. Blanchet, D. Bonenfant, P.H. Rompré, N. Rei, N. Jodoin, V.L. Soland, V. Rey, C. Brefel-Courbon, F. Ory-Magne, O. Rascol (Montreal, QC, Canada)

12:30pm-2:00pm: Characterization of sleep disturbances in a prospective population-based cohort to investigate Parkinson’s disease

S. Tunc, J. Hampf, E.J. Vollstedt, K. Hückelheim, E. Warrlich, C. Kritzinger, C. Bibergeil, J. Graf, C. Klein, M. Kasten (Lübeck, Germany)

12:30pm-2:00pm: Chin EMG variance and dream-enactment behavior during polysomnography in Parkinson’s disease

Y. Shen, K.P. Xiong, C.J. Mao, C.F. Liu (Suzhou, People's Republic of China)

12:30pm-2:00pm: Chronic levodopa treatment accelerates the disorders of circadian rhythm in 6-OHDA induced Parkinson’s disease model

S. Li, Y. Wang, W. Liu, D. Lv, C. Liu (Suzhou, People's Republic of China)

12:30pm-2:00pm: Clinical and biological predictors of excessive daytime sleepiness in early Parkinson’s disease

T. Simuni, J. Long, C. Caspell-Garcia, C.S. Coffey, W. Oertel, S. Lasch, K. Marek, On behalf of the PPMI Sleep Working Group (Chicago, IL, USA)

12:30pm-2:00pm: Clinical correlates of depression and anxiety in patients with Parkinson’s disease

H.D. Hambardzumyan, H.M. Manvelyan (Yerevan, Armenia)

12:30pm-2:00pm: Clinical efficacy of istradefylline on lower urinary tract symptoms in Parkinson’s disease: A prospective study

T. Kitta, I. Yabe, Y. Kanno, H. Chiba, K. Moriya, I. Takahashi, M. Matsushima, H. Sasaki, N. Shinohara (Sapporo, Japan)

12:30pm-2:00pm: Clinical features of Parkinson’s disease patients developing stridor with acute respiratory failure

J. Tashiro, S. Hamada, H. Soma, M. Nonaka, S. Honma, K. Hamada, A. Takei, F. Moriwaka, K. Tashiro (Sapporo, Japan)

12:30pm-2:00pm: Clinical profile and outcome of hospitalized patients with Parkinson’s disease

P. Chatterjee, K. Chatterjee, R. Banerjee, S. Choudhury, B. Mondal, M. Ummekulsum, S.S. Jha, S. Chatterjee, S.S. Anand, H. Kumar (Kolkata, India)

12:30pm-2:00pm: Clinical profile of Parkinson’s disease at the neurology department of Point G Teaching Hospital

T. Coulibaly, A.S. Sissoko, T. Coulibaly, L. Guida, K. Mamadou, G.C. Oumar (Bamako, Mali)

12:30pm-2:00pm: Cognition, vision and visuo-cognition in gait in Parkinson’s disease

S. Stuart, B. Galna, S. Lord, L. Rochester (Newcastle upon Tyne, United Kingdom)

12:30pm-2:00pm: Comorbidity and Parkinson’s disease phenotype, dopaminergic function and CSF biomarkers

T. Yousaf, G. Pagano, F. Niccolini, M. Politis (London, United Kingdom)

12:30pm-2:00pm: Comprehensive motor and non-motor staging system in Parkinson’s disease: Results from a global cross-sectional study

C. Rodriguez-Blazquez, A. Rizos, K.R. Chaudhuri, P. Martinez-Martin, NILS, EUROPAR and MDS Non-Motor PD Study Groups (Madrid, Spain)

12:30pm-2:00pm: Correlations among motor, cognitive, and neuropsychiatric symptoms in Parkinson’s disease without dementia

M. Gang, Y. Nishio, T. Baba, A. Takeda, E. Mori (Sendai, Japan)

12:30pm-2:00pm: Could smell test differ from scans without evidence of dopaminergic deficit and Parkinson’s disease?

S.J. Kang, J.Y. Ahn, H.T. Kim (Seoul, Korea)

12:30pm-2:00pm: Deep brain stimulation of the globus pallidus interna improves performance in complex oculomotor tasks

C.A. Antoniades, P. Rebelo, C. Kennard, T. Aziz, A.L. Green, J.J. FitzGerald (Oxford, United Kingdom)

12:30pm-2:00pm: Dementia in Parkinson’s disease is associated with increased diffusivity in amygdala and external capsule

A. Umemura, T. Oeda, K. Yamamoto, M. Kohsaka, S. Tomita, K. Park, H. Sugiyama, H. Sawada (Kyoto, Japan)

12:30pm-2:00pm: Depression and anxiety in Parkinson’s disease with rapid eye movement sleep behavior disorder

Y. Saitoh, Y. Mukai, T. Sakamoto, M. Murata (Tokyo, Japan)

12:30pm-2:00pm: Depression, anxiety, and apathy in Parkinson’s disease: Insights from neuroimaging studies

M.C. Wen, L.L. Chan, L.C.S. Tan, E.K. Tan (Singapore, Singapore)

12:30pm-2:00pm: Detrusor overactivity is associated with frontal dysfunction in patients with Parkinson’s disease?

T. Uchiyama, T. Yamamoto, K. Suzuki, T. Kadowaki, Y. Watanabe, K. Hashimoto, T. Shingo, K. Kaga, C. Shibata-Yamaguchi, T. Yamanishi, R. Sakakibara, S. Kuwabara, K. Hirata (Tochigi, Japan)

12:30pm-2:00pm: Diagnostic value of combined acute levodopa challenge and olfactory testing to predict Parkinson’s disease diagnosis

M. Rossi, C. Terroba Chambi, A. Bril, P. Millar Vernetti, D. Cerquetti, A. Cammarota, M. Merello (Buenos Aires, Argentina)

12:30pm-2:00pm: Do subjective ratings of the Parkinson’s disease sleep scale-2 converge with results from polysomnography in early Parkinson’s disease? – A report from the DeNoPa cohort

F. Sixel-Döring, J. Zimmermann, M.L. Muntean, B. Mollenhauer, C. Trenkwalder (Kassel, Germany)

12:30pm-2:00pm: Does link between fatigue syndrome and camptocormia in patients with Parkinson’s disease exist?

V. Datieva, O. Levin (Moscow, Russia)

12:30pm-2:00pm: Dopamine transporter, depression and anxiety differences between tremor-predominant and non-tremulous PD are already evident within 2 years of PD diagnosis

Q. Hu, F. Zhou, C.P. Jedynak, L.S. Rosenthal, Z. Mari, B.M. Jedynak (Baltimore, MD, USA)

12:30pm-2:00pm: Dophaminergic therapy and its influence on the olfactory function of patients with Parkinson’s disease

O. Izhboldina, I. Zhukova, N. Zhukova, V. Alifirova, A. Latypova, M. Nikitina, Y. Mironova (Tomsk, Russia)

12:30pm-2:00pm: Double-blind, placebo-controlled trial of a fermented milk containing multiple probiotic strains and prebiotic fiber for constipation associated with Parkinson’s disease

E. Cereda, C. Pacchetti, C. Bolliri, E. Cassani, L. Iorio, C. Pusani, G. Pinelli, G. Privitera, I. Cesari, S.A. Faierman, R. Caccialanza, G. Pezzoli, M. Barichella (Pavia, Italy)

12:30pm-2:00pm: Effects of antidepressants on gait parameters in Parkinson’s disease

D. Martinez-Ramirez, J.C. Giugni, W. Deeb, M.S. Okun, C.J. Hass (Gainesville, FL, USA)

12:30pm-2:00pm: Emotion processing in Parkinson’s disease – Possible link between inability to decode complex emotional stimuli and impairment of executive functions

E. Klimiec, K. Kowalska, P. Pasinska, A. Szyper, T. Dziedzic, A. Slowik, A. Klimkowicz-Mrowiec (Krakow, Poland)

12:30pm-2:00pm: Emotional valence and arousal ratings from rewarding and fearful stimuli are not influenced by levodopa in Parkinson’s disease

T. Serranova, T. Sieger, P. Dušek, E. Ruzicka, R. Jech (Prague, Czech Republic)

12:30pm-2:00pm: Evolution of mild Parkinsonian signs in a longitudinal population-based cohort

J. Hampf, S. Tunc, J. Graf, K. Hückelheim, E.J. Vollstedt, B. Staemmler, C. Klein, M. Kasten (Luebeck, Germany)

12:30pm-2:00pm: Exercise induced analgesia is present in people with Parkinson’s disease

N.E. Allen, N. Moloney, L.M. Hassett, C.G. Canning, S.J.G. Lewis, K. Cruz-Mavignier, B.K. Barry (Lidcombe, Australia)

12:30pm-2:00pm: Exploring association of GBA variants with pre-diagnostic features of PD in the PREDICT-PD cohort: A nested case-control study

L. R'Bibo, N.E. Mencacci, A. Schrag, J.P. Bestwick, L. Peress, J. Masters, G. Giovannoni, A.J. Lees, J. Hardy, N.W. Wood, A.J. Noyce (London, United Kingdom)

12:30pm-2:00pm: First documented case of burning mouth syndrome (BMS) responsive to levodopa-carbidopa intestinal gel (LCIG) infusion in Parkinson’s disease (PD)

X.X. Yu, H. Fernandez (Cleveland, OH, USA)

12:30pm-2:00pm: Frequency and characteristics of diplopia in non-demented patients with Parkinson’s disease

K.A. Schindlbeck, W. Naumann, D.J. Friedrich, S. Schönfeld, A. Maier, F. Klostermann, F. Marzinzik (Berlin, Germany)

12:30pm-2:00pm: Frequency and factors associated with neuropathic pain in patients with Parkinson’s disease

J.F. Pascacio-Astudillo, A.L. Bazàn-Rodrìguez, M. Rodrìguez-Violante, A. Cervantes-Arriaga (Mèxico City, Mexico)

12:30pm-2:00pm: Fundamental differences in Parkinsonian rat limbic regions contribute to anxious behavior and diminished responsiveness to diazepam

K.A. O'Connor, P.J. Feustel, A. Ramirez-Zamora, E. Molho, J.G. Pilitsis, D.S. Shin (Albany, NY, USA)

12:30pm-2:00pm: Gastrointestinal non-motor symptoms in PD: Correlation between objective markers and subjective symptoms

K. Knudsen, T. Fedorova, K. Østergaard, K. Krogh, P. Borghammer (Aarhus C., Denmark)

12:30pm-2:00pm: Gender differences in heart rate variability among patients affected by Parkinson’s disease

P. Solla, E. Erriu, C. Cadeddu, L. Cugusi, G. Costantini, S. Nieddu, M.R. Aresu, R. Farris, M. Meloni, D. Fonti, G. Mercuro, F. Marrosu (Monserrato (Cagliari), Italy)

12:30pm-2:00pm: Headache in patients with Parkinsons disease: Pilot study results

V. Aldinio, N.S. Araoz Olivos, R. Maiola, F.E. Micheli (Buenos Aires, Argentina)

12:30pm-2:00pm: Higher doses of dopamine agonists, impulse control disorders and history of deep brain stimulation (DBS): Risk factors for dopamine agonists withdrawal syndrome (DAWS)?

X. Garcia, S. Patel, M.E. Mohammad, X.X. Yu, K. Sutton, K. O'Donnell, H. Fernandez (Cleveland, OH, USA)

12:30pm-2:00pm: Hyposmia as a predictor of non-motor symptom in patients with de novo Parkinson’s disease

M. Sanoeva, N. Mansurova, A. Prokhorova (Bukhara, Uzbekistan)

12:30pm-2:00pm: Hypothalamic alpha-synuclein pathology and its relation to non-motor symptoms and disease progression in Parkinson’s disease

E. De Pablo-Fernandez, R. Courtney, J.L. Holton, T.W. Warner (London, United Kingdom)

12:30pm-2:00pm: Hypothalamic volume loss is associated with reduced melatonin output in Parkinson’s disease

D.P. Breen, C. Nombela, R. Vuono, P.S. Jones, K. Fisher, D.J. Burn, D.J. Brooks, A.B. Reddy, J.B. Rowe, R.A. Barker (Cambridge, United Kingdom)

12:30pm-2:00pm: Identification of barriers preventing disclosure of non-motor symptoms in Parkinson’s patients to healthcare providers

C.S. Hurt, L. Rixon, K.R. Chaudhuri, R. Moss-Morris, M. Samuel, R.G. Brown (London, United Kingdom)

12:30pm-2:00pm: Identification of premotor Parkinson’s disease

K.C. Hughes, X. Gao, M.A. Schwarzschild, A. Ascherio (Boston, MA, USA)

12:30pm-2:00pm: Idiopathic Parkinson’s disease presenting with dysphagia 15 years before PD diagnosis

T. Munteanu, C. Goggins, D. Costigan, J. Molloy, T. O'Dwyer, T. Lynch (Dublin, Ireland)

12:30pm-2:00pm: Impact of autonomic dysfunction on disease progression and survival in Parkinson’s disease

E. De Pablo-Fernandez, C. Tur, T. Revesz, J.L. Holton, T.T. Warner (London, United Kingdom)

12:30pm-2:00pm: Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson’s patients

T.E. Tong, M.L. Ng, N. Yan (Hong Kong, Hong Kong)

12:30pm-2:00pm: Impaired color discrimination selectively associates with postural instability and gait difficulties in Parkinson’s disease

J.D. Haugen, M.L.T.M. Muller, N.I. Bohnen (Ann Arbor, MI, USA)

12:30pm-2:00pm: Impaired hippocampal neurogenesis associates with serotonergic axonal degeneration in transgenic rat and mouse models of Parkinson’s disease

Z. Kohl, J. Deußer, D. Amato, C.P. Müller, O. Riess, E. Masliah, S. Nuber, J. Winkler (Erlangen, Germany)

12:30pm-2:00pm: Impulse control disorders after STN DBS for Parkinson’s disease

P.G. Frederic, P. Camille, J. Nicolas, S. Abbas, F. Maria, P. Michel (Montreal, QC, Canada)

12:30pm-2:00pm: Impulse control disorders in Parkinson’s disease – Determinants and effect of DBS

A.K. Puligopu, P.K. Pesala, V.V.P. Kagita, R.M. Kandadai, S.A. Jabeen, M.A. Kanikannan, R. Borgohain, A. Kumar (Hyderabad, India)

12:30pm-2:00pm: Increased monosaccharide intake in patients with Parkinson’s disease

E. Schaeffer, A. Schermann, F. Zirbs, D. Berg (Tübingen, Germany)

12:30pm-2:00pm: Influence of motor manifestation and onset’s side on the spectrum of non-motor symptoms in patients with Parkinson’s disease

M.A. Nikitina, I.A. Zhukova, V.M. Alifirova, N.G. Zhukova, O.P. Izhboldina, J.S. Mironova, M.A. Titova, N.G. Brazovskaya (Tomsk, Russia)

12:30pm-2:00pm: Influence of onset age on the progression of non-motor symptoms in Parkinson’s disease: A prospective study from Southwest China

R. Ou, B. Cao, Q. Wei, K. Chen, W. Song, J. Yang, B. Zhao, Y. Wu, H. Shang (Chengdu, People's Republic of China)

12:30pm-2:00pm: Inhibition of nociceptive responses by modulating serotonergic signals at the rostral ventromedial medulla in 6-OHDA-induced Parkinson’s disease rat model

C. Wang, C. Mao, F. Wang, J. Yang, X. Zhang, Y. Yang, C. Liu (Suzhou, People's Republic of China)

12:30pm-2:00pm: Irritable bowel syndrome is more prevalent than functional constipation in Parkinson’s disease: Clinical spectrum and changes in gut microbiota

T. Mertsalmi, V. Aho, P.A.B. Pereira, L. Paulin, E. Pekkonen, P. Auvinen, F. Scheperjans (Helsinki, Finland)

12:30pm-2:00pm: Is continuous twenty four hour blood pressure monitoring a suitable tool in evaluating sleep disturbances in Parkinson’s disease?

M. Hahne, D. Hartmann, C. Thomopoulos, A. Ramih, M. Esther, Y. Guangji, G. Bernd, W. Dirk, R. Heinz, J. Wolfgang (Bad Neustadt, Germany)

12:30pm-2:00pm: Is there any relationship between olfactory dysfunction and memory disorder?

H. Onuma, Y. Kobayashi, A. Kumon, K. Hasegawa (Sagamihara-city, Japan)

12:30pm-2:00pm: Italian olfactory identification test (IOIT) scores correlates with clinical features in Parkinson’s disease

E. Brahimi, N. Tambasco, P. Eusebi, P. Nigro, E. Sacchini, S. Simoni, E. Marsili, F. Ripandelli, M. Romoli, P. Calabresi (Perugia, Italy)

12:30pm-2:00pm: J-FIRST: First-in-Japan observational study of Parkinson’s disease treatments and nonmotor symptoms

T. Maeda, Y. Shimo, S.W. Chiu, T. Yamaguchi, K. Kashihara, Y. Tsuboi, M. Nomoto, N. Hattori, H. Watanabe, H. Saiki (Akita, Japan)

12:30pm-2:00pm: Long-term efficacy of safinamide on mood in Parkinsonian patients with fluctuations

C. Cattaneo, E. Mueller, M. Sardina (Bresso, Italy)

12:30pm-2:00pm: Longitudinal assessment of sleep in an incident Parkinson’s disease cohort

S.T. O'Dowd, G.W. Duncan, T.K. Khoo, A.J. Yarnall, R.A. Lawson, D.J. Burn, K.N. Anderson (Newcastle upon Tyne, United Kingdom)

12:30pm-2:00pm: Longitudinal evolution of excessive daytime sleepiness in early Parkinson’s disease

T. Simuni, C. Caspell-Garcia, J. Long, C.S. Coffey, W. Oertel, S. Lasch, K. Marek, On behalf of the PPMI Sleep Working Group (Chicago, IL, USA)

12:30pm-2:00pm: Longitudinal evolution of possible REM sleep behavior disorder in early Parkinson’s disease

W. Oertel, T. Simuni, C. Caspell-Garcia, J. Long, C.S. Coffey, A. Iranzo, G. Mayer, L. Chahine, S. Lasch, K. Marek, On behalf of the PPMI Sleep Working Group (Marburg, Germany)

12:30pm-2:00pm: Measurement of night time sleep using an accelerometry based system

M. Horne, S. McGregor, G. Hamilton, D. O'Driscoll, R. Blaze, P. Churchward (Parkville, Australia)

12:30pm-2:00pm: Modulation and mechanism for the neuroprotective effects of 17-beta-estradiol: Relevance to depressive symptoms in Parkinson’s disease

P. Kumar, N. Baquer (New Delhi, India)

12:30pm-2:00pm: Motor and non-motor symptoms in Parkinson’s disease: Correlation and impact on quality of life and activities of daily living

P. Bugalho, T. Lampreia, R. Miguel, M. Mendonça, A. Caetano, R. Barbosa (Lisbon, Portugal)

12:30pm-2:00pm: Motor features and response to levodopa in Parkinson’s disease with normal olfactory function

M. Rossi, A. Medina Escobar, A. Bril, P. Millar Vernetti, J.I. De Palo, D. Cerquetti, M. Merello (Buenos Aires, Argentina)

12:30pm-2:00pm: Motor rigidity selectively associates with impaired odor identification in Parkinson’s disease

J.D. Haugen, M.L.T.M. Muller, V. Kotagal, K.A. Frey, R.L. Albin, N.I. Bohnen (Ann Arbor, MI, USA)

12:30pm-2:00pm: Musical ear syndrome as a presenting symptom of Lewy body disorder

S.J. Song, D. Lee, Y.N. Kwon, T.B. Ahn (Seoul, Korea)

12:30pm-2:00pm: Neurocognitive domains of impulsivity in Parkinson’s disease (PD) and the effects of dopaminergic replacement therapy (DRT)

M. Sousa, N. Canário, F. Moreira, C. Duarte, M. Castelo-Branco, C. Januário (Coimbra, Portugal)

12:30pm-2:00pm: Neuropsychiatric disturbances in Parkinson’s disease patients’ with chronic pain

G. Pavlic, I. Moldovanu, N. Diaconu, L. Rotaru (Chisinau, Republic of Moldova)

12:30pm-2:00pm: Neuropsychological assessment in the Luxembourg Parkinson’s cohort (HELP-PD)

G. Hipp, P. Kolber, K. Roomp, M. Kerschenmeyer, S.K. Mosch, L. Longhino, A. Schweicher, M. Faltz, V.P. Satagopam, N. Goncharenko, M. Gantenbein, M. Vaillant, F. Betsou, A. Chioti, R. Schneider, R. Schneider, R. Balling, N.J. Diederich, R. Krüger (Belvaux, Luxembourg)

12:30pm-2:00pm: Nighttime sleep problems in patients with Parkinson’s disease: Risk factors and longitudinal associations

K. Zhu, J.J. van Hilten, J. Marinus (Leiden, Netherlands)

12:30pm-2:00pm: Non motor symptoms burden and motor staging of Parkinson’s disease: Evidence for dichotomy and non-motor dominant subtypes from analysis of 249 cases

K. Ray Chaudhuri, A. Sauerbier, T. Thavayogarajah, A. Rizos, L. Perkins, C. Rodriguez Blazquez, P. Martinez-Martin, On behalf of EUROPAR, the MDS Non-Motor PD Study Group, The NILS Group (London, United Kingdom)

12:30pm-2:00pm: Non motor symptoms of Parkinson’s disease: Prevalence and impact on quality of life

M. Chraa, K. Choulli, N. Kissani (Marrakech, Morocco)

12:30pm-2:00pm: Non-motor symptoms (NMS) as a determinant of caregiver burden in a cohort of older patients with Parkinson’s disease (PD)

S. Gangadharan, N. Bareham, A. Johnson, M. Rees, A. Withenage, C.P. Padmakumar (Newcastle, Australia)

12:30pm-2:00pm: Non-motor symptoms in a PPMI cohort of p.A53T α-synuclein mutation-related and sporadic Parkinson’s disease patients

C. Koros, M. Stamelou, I. Beratis, N. Papagiannakis, A.M. Simitsi, D. Papadimitriou, S. Fragiadaki, D. Kontaxopoulou, S.G. Papageorgiou, L. Stefanis (Athens, Greece)

12:30pm-2:00pm: Non-motor symptoms in advanced Parkinson’s disease patients treated with levodopa/carbidopa intestinal gel, deep brain stimulation, or continuous subcutaneous apomorphine: A systematic literature review and pooled analysis

K.R. Chaudhuri, E. Terasawa, Y. Jalundhwala, D. Macaulay, R. Ayyagari, Z.Y. Zhou, T. Marshall, K. Chatamra, A. Yucel, K. Sail (London, United Kingdom)

12:30pm-2:00pm: Non-motor symptoms in PD candidates for DBS treatment

M.G. dos Santos Ghilardi, R.C.R. Martinez, R.G. Cury, J.R. Aranha, M.J. Teixeira, E.R. Barbosa, E.T. Fonoff (Sao Paulo, Brazil)

12:30pm-2:00pm: Non-motor symptoms trajectory in Parkinson’s disease: Magnitude and importance of the change

C. Rodriguez-Blazquez, A. Rizos, K.R. Chaudhuri, P. Martinez-Martin, NILS, EUROPAR and the MDS Non Motor PD Study Groups (Madrid, Spain)

12:30pm-2:00pm: Nutritional status and quality of life in patients with Parkinson’s disease in a tertiary hospital in Northeast Mexico

I.E. Estrada, P. Ancer, H.J. Villarreal, C. Lopez, J. Rocha, A. Treviño, J.J. Peña, D. Ortiz (Monterrey, Mexico)

12:30pm-2:00pm: Olfactory deficit characterization in Parkinson’s disease

A.M. Crespo-Cuevas, L. Ispierto, A. Planas, D. Vilas, A. Planas, J. Sanchez, I. Isern, J. De Haro, R. Alvarez (Badalona, Spain)

12:30pm-2:00pm: Olfactory loss – early non-motor symptom in Parkinson’s disease

A. Kadirova, K. Mirzaeva, G. Rakhimbaeva (Tashkent, Uzbekistan)

12:30pm-2:00pm: Olfactory testing in differential diagnosis of atypical essential tremor and tremor-dominant Parkinson’s disease

O. Izhboldina, I. Zhukova, N. Zhukova, V. Alifirova, A. Latypova, M. Nikitina, Y. Mironova (Tomsk, Russia)

12:30pm-2:00pm: Orthostatic intolerance and falls in Parkinson’s disease

A. Fanciulli, C. Dallinger, G. Goebel, R. Granata, S. Duerr, F. Sprenger, F. Krismer, C. Mueller, S. Boesch, M. Nocker, C. Scherfler, K. Seppi, W. Poewe, G.K. Wenning (Innsbruck, Austria)

12:30pm-2:00pm: P100 latency of pattern reversal visual evoked potential and visual hallucination in Parkinson’s disease

M. Kohsaka, T. Oeda, A. Umemura, S. Tomita, K. Park, K. Yamamoto, H. Sugiyama, H. Sawada (Kyoto, Japan)

12:30pm-2:00pm: Pain correlates with sleep disturbances in Parkinson’s disease

Y. Fu, C. Mao, L. Ma, M. Ding, Y. Wang, C. Liu (Suzhou, People's Republic of China)

12:30pm-2:00pm: Parasacral effects of electrical stimulation on lower urinary tract symptoms and constipation in patients with Parkinson’s disease: Preliminary data

I.V. Brandi, L.F. Silva, A.M. Lanzarini, A.F.A. Musengante (Salvador, Brazil)

12:30pm-2:00pm: Parkinson’s disease prodromal dysautonomia versus pure autonomic failure and MSA

M. Rosso, A. Merola, A.J. Espay, S. Maule, M. Zibetti, A. Romagnolo, L. Lopiano (Torino, Italy)

12:30pm-2:00pm: Parkinsonism risk factors in Salt Lake City, Utah

D. Shprecher, K. Gannon, M. Halverson, R. Savica (Sun City, AZ, USA)

12:30pm-2:00pm: Preliminary results of a cross-linguistic comparison on dysarthria in Parkinson’s disease

J. Sadat, R. Cardoso, H. Santos, J. Carvalho, I. Guimarães, F. Viallet, J.J. Ferreira, S. Pinto (Aix-en-Provence, France)

12:30pm-2:00pm: Premotor symptoms as prognostic indicators of Parkinson’s disease: A nationwide population-based and case-control study

M.H. Chang (Taichung, Taiwan)

12:30pm-2:00pm: Prevalence and risk factors for orthostatic hypotension in early PD

C. McDonald, R.A. Lawson, G.W. Duncan, T.K. Khoo, D.J. Brooks, R.A. Barker, A.J. Yarnall, D.J. Burn (Newcastle upon Tyne, United Kingdom)

12:30pm-2:00pm: Prevalence and risk factors of orthostatic hypotension in Thai Parkinson’s disease patients

S. Klanbut, S. Wongwiwatthananukit, C. Suthisisang, R. Bhidayasiri, S. Phattanarudee (Bangkok, Thailand)

12:30pm-2:00pm: Prodromal Parkinson’s disease in Argentinean patients with Gaucher disease type 1: Preliminary report

E.M. Gatto, J.L. Etcheverry, N. Basack, L. Aversa, N. Fernández Escobar, B. Soberón, A. Sanguinetti, M. Cesarini, G. Drelichman, E.M. Gatto (Buenos Aires, Argentina)

12:30pm-2:00pm: Pulmonary dysfunction in Parkinson’s disease: A feature of early disease?

G. Baille, T. Perez, D. Devos, L. Defebvre, C. Moreau (Lille, France)

12:30pm-2:00pm: Quality of life after subthalamic stimulation depends on non-motor symptoms in Parkinson’s disease

H.S. Dafsari, L. Weiss, M. Silverdale, P. Reddy, A. Rizos, M. Samuel, E. Perrier, J. Evans, K. Ashkan, J.N. Petry-Schmelzer, V. Visser-Vandewalle, A. Antonini, P. Martinez-Martin, K.R. Chaudhuri, L. Timmermann (Cologne, Germany)

12:30pm-2:00pm: RBD increase non-motor symptom in Parkinson’s disease

Y. Wu, Y. Liu, X. Zhu, X. Zhang, S. Kuo, W.G. Ondo (Shanghai, People's Republic of China)

12:30pm-2:00pm: Rehabilitation of dysphagia in Parkinson’s disease: Effect of chin-down postural maneuver

A. Ayres, G.P. Jotz, C.R.M. Rieder, M.R. Olchik (Porto Alegre, Brazil)

12:30pm-2:00pm: Relationship between cognitive functions and striatal 123I-FP-CIT uptake in Parkinson’s disease

H. Sawada, T. Sekiguchi, M. Takahashi, A. Inaba, S. Orimo (Tokyo, Japan)

12:30pm-2:00pm: Relationship between fatigue and sleep disturbances in patients with Parkinson’s disease: A study using Parkinson’s disease sleep scale-2

K. Suzuki, A. Numao, T. Kadowaki, S. Suzuki, Y. Watanabe, M. Miyamoto, T. Miyamoto, T. Uchiyama, K. Hashimoto, H. Fujita, Y. Watanabe, T. Matsubara, K. Hirata (Mibu, Japan)

12:30pm-2:00pm: Retinal nerve fiber layer thinning: A window into rapid eye movement sleep behavior disorders in Parkinson’s disease

C.J. Mao, Z.J. Yang, J. Wei, J.R. Zhang, Y.P. Yang, C.F. Liu (Suzhou, People's Republic of China)

12:30pm-2:00pm: Risks and predictive factors for pneumonia amongst Parkinson’s disease patients with dysphagia

K.H. Goh, H.L. Ng, K.Y. Tay, S. Acharyya, S.Y.E. Ng, J.P.L. Boo, A.H.J. Kooi, W. Li, W.L. Au, L.C.S. Tan (Singapore, Singapore)

12:30pm-2:00pm: Sleep deprivation (SD) amongst carers of patients with Parkinson’s disease (PD)

D. Kulatunga, H. Avery, A.K. Chatterjee, A. Plowman, J. Caffrey, S. Pradhan (Reading, United Kingdom)

12:30pm-2:00pm: Sleep disordered breathing in patients of Parkinson’s disease with REM sleep behavior disorder

R. Yadav, N. Kamble, J. Saini, K. Kumar, P.K. Pal (Bangalore, India)

12:30pm-2:00pm: Speech evaluation in Parkinson’s disease using a transcribed version of the Frenchay dysarthria assessment

M. Löhle, A. Zenker, R. Jäckel, C. Bosredon, R. Hoffmann, A. Storch (Rostock, Germany)

12:30pm-2:00pm: Survey of prodromal symptoms of Parkinson’s disease in Japan

M. Yogo, M. Morita, M. Suzuki (Katsushika-ku, Japan)

12:30pm-2:00pm: Swallowing in individuals with Parkinson’s disease: A study of FEES

A. Ayres, M.R. Olchik, C.R.M. Rieder, G.P. Jotz (Porto Alegre, Brazil)

12:30pm-2:00pm: Systematic literature review of droxidopa in clinical trials for neurogenic orthostatic hypotension (nOH) in parkinsonism

S. Tashiro, K. Dashtipour, J.J. Chen, K. Frei, E. Rashidian (Loma Linda, CA, USA)

12:30pm-2:00pm: The combined effect of REM sleep behavior disorder and hyposmia on cognition and motor phenotype in Parkinson’s disease

S.B. Koh, S.H. Kang, H.M. Lee, W.K. Seo, J.H. Kim (Seoul, Korea)

12:30pm-2:00pm: The effects of dysphagia course for speech & language pathologist in Israel on clinical-related knowledge and confidence

Y. Manor, H. Shabtai, O. Sella (Tel-Aviv, Israel)

12:30pm-2:00pm: The effects of fluvoxamine maleate in a post-natal stress rat model of neurodegeneration

E. Dalle, W. Daniels, M. Mabandla (Durban, South Africa)

12:30pm-2:00pm: The evolution of REM sleep behavior disorder in Parkinson’s disease: The DeNoPa cohort at 2-year follow-up

F. Sixel-Döring, J. Zimmermann, A. Wegener, B. Mollenhauer, C. Trenkwalder (Kassel, Germany)

12:30pm-2:00pm: The heterogeneity of fatigue in different stages of Parkinson’s disease

M.R. Nodel, N.N. Yakhno (Moscow, Russia)

12:30pm-2:00pm: The influences of STN-DBS and levodopa on cardiovascular autonomic function in patients with Parkinson’s disease: Evaluated by trigonometric regressive spectral analysis

K. Li, M. Wolz, R. Haase, H. Reichmann, T. Ziemssen (Dresden, Germany)

12:30pm-2:00pm: The non-motor side of the honey-moon period of Parkinson’s disease

R. Erro, M. Picillo, C. Vitale, M. Amboni, M. Moccia, M.T. Pellecchia, P. Barone (London, United Kingdom)

12:30pm-2:00pm: The non-motors symptoms in Parkinson’s disease patients with freezing of gait

H.C. Huang, M.K. Lu, C.H. Tsai (Taichung, Taiwan)

12:30pm-2:00pm: The prevalence of constipation and irritable bowel syndrome in Parkinson’s disease patients according to Rome III diagnostic criteria

T. Mishima, J. Fukae, S. Fujioka, K. Inoue, Y. Tsuboi (Fukuoka, Japan)

12:30pm-2:00pm: The prevalence of gastrointestinal disorders and non-motor symptoms in a cohort of patients with Parkinson’s disease

P.J. Hobson, J.R. Meara (Rhyl, United Kingdom)

12:30pm-2:00pm: The relation between dream content and non-motor symptoms in Parkinson’s disease and idiopathic REM sleep behavior disorder

P. Bugalho, T. Lampreia, R. Miguel, M. Mendonça, A. Caetano, R. Barbosa (Lisbon, Portugal)

12:30pm-2:00pm: The relationship between the cognitive phenotype and 5-HT2A receptor in PD with visual hallucinations

S.S. Cho, A.P. Strafella, S. Duff-Canning, M. Zurowski, A.C. Vijverman, V. Bruno, C. de Aquino, M. Criaud, P.M. Rusjan, S. Houle, S.H. Fox (Toronto, ON, Canada)

12:30pm-2:00pm: Unawareness of causes of sudden deterioration in Parkinson’s patients in movement disorder clinic

V. Paramanandam, D.A. Olszewska, C. Fearon, B. Magennis, T. Lynch (Dublin, Ireland)

12:30pm-2:00pm: Unusual motor and non-motor symptoms and signs in the early stage of Parkinson´s disease

H.A.G. Teive, D.C. Bertucci, R.P. Munhoz (Curitiba, Brazil)

12:30pm-2:00pm: Use of the physiotherapy in the treatment of initial stages of Parkinson’s disease

O.L. Tondiy (Kharkiv, Ukraine)

12:30pm-2:00pm: Usefulness of total neuropathy score revised as a screening tool of peripheral neuropathy in patients with Parkinson’s disease

P.W. Ko, J.S. Park, K. Kang, H.W. Lee (Daegu, Korea)

12:30pm-2:00pm: Validation study of Parkinson anxiety scale, Czech version

N. Zemanová, M. Baláz (Brno, Czech Republic)

12:30pm-2:00pm: Verb naming in hypokinetic and hyperkinetic movement disorders: Preliminary results

E. Bayram, M.C. Akbostanci (Ankara, Turkey)

12:30pm-2:00pm: Vocal fold augmentation in patients with Parkinson’s disease: A case series and review of the literature

A.A. Thekdi (Houston, TX, USA)

« View all sessions from the 20th International Congress.